The optimal treatment strategy for men with localised prostatic cancer of low and intermediate risk is an actively evolving field. It is important to strike a balance between maximal oncological control and minimal treatment-related complications, which helps preserve the patients' quality of life. MR-guided transurethral ultrasound ablation (TULSA) has emerged as a minimally invasive treatment option for this group of patients. This article aims to provide of a background on TULSA technology, a step-by-step procedural guide of MR-guided TULSA and to summarise the current evidence of TULSA in management of localised prostatic cancer, as well as other potential indications.
Cardiovascular and interventional radiology. 2024 Mar 15 [Epub ahead of print]
Kin Fen Kevin Fung, Roberto Luigi Cazzato, Thibault Tricard, Pierre D E Marini, Gregory Bertucci, Pierre-Alexis Autrusseau, Guillaume Koch, Julia Weiss, Julien Garnon, Hervé Lang, Afshin Gangi
Department of Radiology, University of Hong Kong, Hong Kong, Hong Kong. ., Department of Interventional Radiology, University Hospital Strasbourg, Strasbourg, France., Department of Urology, University Hospital Strasbourg, Strasbourg, France.